Elaine DeLack
Founder & CEO
Elaine DeLack, Founder and CEO of MedDEV, inc. has developed and patented treatments for multiple sclerosis, depression, bi-polar depressive disorder, and autism spectrum disorder. Her theoretical and study results regarding her treatment research for multiple sclerosis has been published in the scientific journals Multiple Sclerosis Clinical and Laboratory Research, and the Alternative Medicine Review. Ms. Delack is the founder of MedDEV, Inc. (established in 2006), and EDMS LLC (established in 1998).
Ms. DeLack’s foray into medical research occurred after years of working with elderly and chronically ill patients in transitional care facilities.
A board-certified RN, DeLack’s passion for research intensified after she was diagnosed with MS more than two decades ago. Working as a team with physicians and medical research professionals, Elaine developed a treatment that proved to be an effective treatment for her and for thousands of MS sufferers in the US and abroad.
After her success with Prokarin, Ms. DeLack has lectured throughout the US and Canada to physicians, pharmacists and patients.
